Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle East Respiratory Syndrome Coronavirus.

The Journal of infectious diseases(2022)

引用 8|浏览7
暂无评分
摘要
REGN3048 and REGN3051 in combination were well tolerated. The clinical and preclinical data support further development for the treatment or prophylaxis of MERS-CoV infection.
更多
查看译文
关键词
MERS,animal efficacy,first-in-human study,immunogenicity,monoclonal antibodies,pharmacokinetics,safety,tolerability
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要